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Abstract  26 
Pyroptosis is a lytic form of cell death that is induced by inflammatory caspases upon activation 27 
of the canonical or non-canonical inflammasome pathways. These caspases cleave gasdermin 28 
D (GSDMD) thereby generating an N-terminal GSDMD fragment that executes pyroptosis by 29 
forming membrane pores. Here, we find that calcium influx through GSDMD pores serves a 30 
signal for cells to initiate membrane repair by recruiting the ESCRT machinery to damaged 31 
membrane areas, such as the plasma membrane. Inhibition of the ESCRT-III machinery 32 
strongly enhances pyroptosis and IL-1b release in both human and murine cells after canonical 33 
or non-canonical inflammasome activation. These results not only attribute an anti-34 
inflammatory role to membrane repair by the ESCRT-III system, but also provide insight in 35 
general cellular survival mechanisms during pyroptosis. 36 
 37 
Main text  38 
Gasdermin D (GSDMD) is a pore-forming protein that causes pyroptosis, a necrotic cell death 39 
that is initiated after inflammasome activation (1–3). Detection of pathogen- or host-derived 40 
danger signals by inflammasomes triggers the activation of inflammatory caspases, caspase-1 41 
and -11 in mice or caspase-1 and -4 in humans, which cleave GSDMD to release autoinhibition 42 
on its N-terminal domain (GSDMDNT) (1, 2). The GSDMDNT targets the plasma membrane 43 
and organelles, where it forms large pores to execute pyroptosis (4–7). Damage to the plasma 44 
membrane does not necessarily result in cell death, since it has been observed that the influx 45 
of Ca2+ ions from the extracellular milieu triggers repair programs involving either the 46 
endocytosis of damaged membrane or its shedding in form of ectosomes (8–11). The later 47 
mechanism relies on components of endosomal sorting complexes required for transport 48 
(ESCRT)-0, -III, and associated factors that control ESCRT recruitment and disassembly, and 49 
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has been specifically implicated in the restoration of plasma membrane integrity during 50 
necroptosis (12) or upon chemical or laser-induced damage (10, 11). 51 
To investigate if cells repair membranes damaged by GSDMD pores, we imaged the 52 
disruption of the electrochemical gradient (Ca2+ dye Fluo-8) and loss of membrane integrity 53 
(Propidium iodide, PI) in mouse bone marrow-derived macrophages (BMDMs) that were left 54 
untreated or transfected with LPS to activate caspase-11. Within 2 hours, up to 50% of LPS-55 
transfected wildtype (WT) BMDMs underwent pyroptosis as indicated by strong PI signal 56 
(PIhi) (Fig. S1A). A marked spike of Fluo-8 signal preceded the PIhi signal, indicating a loss of 57 
membrane integrity and Ca2+ influx (Fig. 1A-B, S1B-D, Movie 1-2). By contrast, Fluo-8 or PI 58 
signals did not change in Casp11−/− or Gsdmd−/− BMDMs (Fig. 1B, S1C-D, Movie 1-2). 59 
Unexpectedly, we found that Ca2+-influx-negative WT BMDMs that maintained the 60 
electrochemical gradient gradually acquired a low-level PI staining (Fig. 1C). This PIlo signal 61 
only reached 1/10 of the PIhi signal observed in WT BMDMs that had lost membrane integrity 62 
upon LPS transfection. Furthermore, neither unstimulated WT BMDMs (Fig. 1A) nor LPS-63 
transfected Casp11−/− or Gsdmd−/− cells showed such a PIlo signal (Fig. 1C). This confirmed 64 
that low-level PI influx was caused by GSDMD pores, and given the absence of a Fluo-8 signal 65 
peak, implied that PIlo cells had repaired their plasma membrane to prevent lysis. 66 
Next, we used the Ca2+ chelators BAPTA-AM or EDTA to block membrane repair as done 67 
previously (10, 11). Ca2+ chelators increased the levels of cell lysis and lactate dehydrogenase 68 
(LDH) release from WT BMDMs after LPS transfection in a dose dependent manner (Fig. 1D, 69 
S1A, S2). Importantly, Ca2+ chelation was not cytotoxic (Fig. 1D, S2A) and did not enhance 70 
LPS transfection or caspase-11 activation as assessed by immunoblotting for GSDMDNT (Fig. 71 
1E, S3A). BAPTA-AM also increased caspase-4-dependent pyroptosis without significantly 72 
altering GSDMD processing in HeLa cells infected with ΔsifA Salmonella typhimurium (Fig. 73 
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1F-G, S3B)(13). In summary, Ca2+ chelation enhanced pyroptosis in human and mouse cells, 74 
potentially by preventing the initiation of plasma membrane repair. 75 
ESCRT proteins target membranes during membrane repair to form a punctate pattern (10, 76 
12). Consistently, CHMP4 puncta were observed in HeLa cells, expressing CHMP4-GFP from 77 
its endogenous promoter (14), after S. typhimurium infection, GSDMDNT expression, or 78 
perforin treatment (control), but not in untreated cells (Fig. S4, Movie 3). Moreover, Ca2+ 79 
chelation significantly reduced the number of CHMP4-GFP-puncta-positive cells (Fig. 2A), 80 
indicating that ESCRT assembly requires Ca2+ influx via GSDMD pores. Next, we transfected 81 
CHMP4-mCherry or CHMP4-GFP into HEK293T cells stably expressing caspase-1 fused with 82 
a modified FKBP domain (DmrB-Casp-1). Following dimerization and activation of DmrB-83 
Casp-1 with B/B homodimerizer, cells underwent pyroptosis as demonstrated by 84 
morphological changes and plasma membrane Annexin-V staining (Fig. 2B-C, movie 4-6). 85 
CHMP4 re-localized to a punctate pattern in DmrB-Casp-1-transgenic HEK293Ts expressing 86 
either high (Fig. 2B-C, S5A-C arrows) or low levels of CHMP4 (Fig. S5B), and similar 87 
CHMP4 puncta were detected after activation of DmrB-Casp-11 (Fig. S6A). Although many 88 
CHMP4 puncta clearly localized to the plasma membrane (Fig. 2B-C, S4-6, movie 6), puncta 89 
also formed in the cytoplasm, presumably on intracellular organelles. During necroptosis, the 90 
ESCRT machinery promotes the formation of Annexin-V+ plasma membrane vesicles, which 91 
were proposed to remove damaged plasma membrane areas (12). Similar Annexin-V positive 92 
vesicles were detected budding-off from HEK293T cells after activation of DmrB-Casp-1 (Fig. 93 
2C-D, S5D, Movie 5) or DmrB-Casp-11 (Fig. S6B). Importantly, these vesicles showed clear 94 
CHMP4 puncta at their neck (Fig. 2C, S5D, S6B), and when GSDMD-GFPinternal (Fig. S7A) 95 
was co-expressed, it localized close to CHMP4-mCherry puncta on the cell periphery (Fig. 96 
S7B) and on the membrane of Annexin-V+ vesicles (Fig. 2D, S7C), suggesting that ESCRT-97 
induced ectosomes remove GSDMD pores from the plasma membrane. 98 
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Next, we examined the impact of ESCRT-III inactivation on inflammasome effector 99 
functions. We transiently expressed either WT or dominant-negative CHMP3 or VPS4A in 100 
immortalized mouse BMDMs (iBMDMs) or HeLa cells (Fig. S8A-C), since prolonged ESCRT 101 
depletion is cytotoxic (10, 12). Expression of dominant-negative VPS4AE228Q or CHMP31-179 102 
inhibited ESCRT disassembly as verified by a punctate pattern (Fig. S8D), and reduced cell 103 
viability after 20-24 hours of expression (Fig. S8E), prompting us to restrict our experiments 104 
to a maximum 15 hours post-induction with doxycycline. Expression of VPS4AE228Q in WT 105 
iBMDMs resulted on 2-to-4-fold higher cell death levels after LPS transfection compared to 106 
VPS4AWT-expressing controls (Fig. 3A-B, S9, Movies 7-8) and decreased recovery after LPS 107 
transfection (Fig. S10). ESCRT inactivation also strongly enhanced IL-1b release after LPS 108 
transfection (Fig. 3C), but importantly neither enhanced LDH or cytokine release from 109 
untreated, Casp11−/− or Gsdmd−/− cells (Fig. S11). IL-1b release after non-canonical 110 
inflammasome activation depends on GSDMD-induced K+ efflux and subsequent activation of 111 
the NLRP3-caspase-1 pathway (15, 16). Since LPS-transfected WT iBMDMs expressing 112 
VPS4AE228Q had higher levels of processed, activated caspase-1 and released more mature IL-113 
1b than VPS4AWT-expressing control cells (Fig. 3C-D), we speculated that it is due to 114 
enhanced K+ efflux through increased GSDMD pore formation. Consistently, and in agreement 115 
with previous reports (15), cytokine release but not cell death was attenuated by treatment with 116 
the NLRP3 inhibitor MCC950 or high extracellular K+ (Fig. 3E, S12A). 117 
We next assayed GSDMD processing and found that GSDMDNT levels were slightly enhanced 118 
in VPS4AE228Q transgenic iBMDMs compared to VPS4AWT transgenic iBMDMs at high LPS 119 
concentrations (Fig. 3F). We postulated that enhanced GSDMD processing was caused by 120 
enhanced NLRP3 inflammasome activation (Fig. 3E, S12A), and was thus caspase-1-121 
dependent. Indeed, GSDMD processing was unchanged between VPS4AE228Q and VPS4AWT-122 
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expressing iBMDMs in the presence of MCC950 (Fig. 3F, S12B), confirming that ESCRT 123 
negatively regulates pyroptosis downstream of caspase-11 activation and GSDMD processing.  124 
To study the role of ESCRT-associated proteins, we knocked-down expression of ESCRT-125 
I/III proteins, and two proteins, ALG2 and ALIX, implicated in Ca2+-dependent recruitment of 126 
ESCRTs (8). As spontaneous necroptosis occurs upon ESCRT depletion (12), we did all 127 
knockdowns in Ripk3−/− iBMDMs (12), which remained viable despite successful protein 128 
depletion (Fig. S13A-E). Knockdown of CHMP3, VPS4A and VPS4B significantly enhanced 129 
pyroptosis and IL-1b release in Ripk3−/− iBMDMs transfected with LPS (Fig. 3G). By contrast, 130 
single- or double-knockdowns of ALIX and ALG-2 had no impact on pyroptosis (Fig. 3G). 131 
ALG2 and ALIX might act redundantly with TSG101 (17), but simultaneous depletion was not 132 
possible due to the cytotoxicity of TSG101 depletion in BMDMs (Fig. S13F). 133 
ESCRT inactivation also enhanced pyroptosis in human cells infected with ΔsifA S. 134 
typhimurium (Fig. S14A-D). Here ESCRTs appeared to have an additional function upstream 135 
of inflammasomes, since ESCRT inactivation resulted in higher levels of ruptured, Galectin-136 
3+ Salmonella-containing vacuoles (Fig. S15A-C), despite equal levels of bacterial invasion 137 
(Fig. S14E-F). This implied that ESCRTs could repair damaged vacuoles/endosomes as 138 
published recently (17) and thereby control bacterial escape into the cytosol. However, the 139 
elevated levels of   cytosolic bacteria in ESCRT-depleted cells had only a negligible impact on 140 
GSDMD processing at the timepoints examined (Fig. S15D-F).  141 
We next asked if ESCRTs also regulate cell death after canonical inflammasome activation. 142 
Ca2+ chelation significantly enhanced pyroptosis after DNA transfection of BMDMs (Fig. 143 
S16A-B), without changing caspase-1 processing (Fig. S16C-D). Furthermore, ESCRT 144 
depletion significantly enhanced cell death and IL-1b release in iBMDMs following NLRC4 145 
activation with log-phase S. typhimurium, but did not enhance ASC speck formation or 146 
processing of caspase-1 or GSDMD (Fig. 4A-B, S17), indicating that ESCRTs restrict 147 
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pyroptosis downstream of GSDMD. To further exclude any effects of ESCRT depletion on the 148 
upstream signals that control caspase-1 activation, we used DmrB-Casp-1-transgenic 149 
HEK293T cells. Activation of DmrB-Casp-1 caused pyroptosis with faster kinetics in cells 150 
expressing dominant-negative VPS4AE228Q or CHMP31-179 compared to cells expressing the 151 
WT proteins, in particular if DmrB-Casp-1 activity was limited by adding an inhibitory 152 
washout compound (Fig. 4C, S18A). B/B homodimerizer enhanced pyroptosis in ESCRT-153 
deficient compared to ESCRT-proficient cells across a variety of concentrations (Fig 4D, 154 
S18B). Importantly, ESCRT inactivation did not affect GSDMD processing (Fig 4E, S18C) 155 
and only enhanced pyroptosis in DmrB-Casp-1-transgenic HEK293Ts when GSDMD was co-156 
expressed (Fig. S18D-E). Finally, ESCRT-inactivation also enhanced IL-1b release, as shown 157 
using pro-IL-1b-transgenic HEK293T cells (Fig 4F, S18F). 158 
Thus, in a variety of cell lines and systems, the ESCRT machinery dampens GSDMD pore-159 
mediated cell death and negatively regulates IL-1b secretion following canonical and non-160 
canonical inflammasome activation. We propose that ESCRTs play a central role in removing 161 
GSDMD pores from the plasma membrane in the form of ectosomes and that membrane repair 162 
could allow cells to restrict pyroptosis while permitting limited GSDMD-dependent cytokine 163 
release (18, 19). Our results place ESCRTs downstream of caspase activation and GSDMD 164 
processing, but do not exclude that ESCRTs also control the activation of inflammasomes, for 165 
example by repairing damaged bacteria-containing vacuoles and thus restricting cytosolic 166 
access of bacteria-derived ligands. Further experiments are needed to assess this aspect of 167 
ESCRTs and to determine if ESCRT-induced vesicles transport cytokines and danger signals.  168 
 169 
References and Notes 170 
1.  N. Kayagaki et al., Caspase-11 cleaves gasdermin D for non-canonical inflammasome 171 
signalling. Nature. 526, 666–71 (2015). 172 
 - 8 - 
2.  J. Shi et al., Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell 173 
death. Nature. 526, 660–5 (2015). 174 
3.  P. Broz, V. M. Dixit, Inflammasomes: mechanism of assembly, regulation and signalling. 175 
Nat Rev Immunol. 16, 407–20 (2016). 176 
4.  L. Sborgi et al., GSDMD membrane pore formation constitutes the mechanism of 177 
pyroptotic cell death. EMBO J. 35, 1766–78 (2016). 178 
5.  R. A. Aglietti et al., GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in 179 
membranes. Proc. Natl. Acad. Sci. U.S.A. 113, 7858–7863 (2016). 180 
6.  J. Ding et al., Pore-forming activity and structural autoinhibition of the gasdermin family. 181 
Nature. 535, 111–6 (2016). 182 
7.  X. Liu et al., Inflammasome-activated gasdermin D causes pyroptosis by forming 183 
membrane pores. Nature. 535, 153–8 (2016). 184 
8.  N. W. Andrews, P. E. Almeida, M. Corrotte, Damage control: cellular mechanisms of 185 
plasma membrane repair. Trends Cell Biol. 24, 734–42 (2014). 186 
9.  C. Tam et al., Exocytosis of acid sphingomyelinase by wounded cells promotes 187 
endocytosis and plasma membrane repair. J Cell Biol. 189, 1027–38 (2010). 188 
10.  A. J. Jimenez et al., ESCRT machinery is required for plasma membrane repair. Science. 189 
343, 1247136 (2014). 190 
11.  L. L. Scheffer et al., Mechanism of Ca(2)(+)-triggered ESCRT assembly and regulation 191 
of cell membrane repair. Nat Commun. 5, 5646 (2014). 192 
12.  Y. N. Gong et al., ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell 193 
Death and Its Consequences. Cell. 169, 286-300 e16 (2017). 194 
13.  J. Shi et al., Inflammatory caspases are innate immune receptors for intracellular LPS. 195 
Nature. 514, 187–192 (2014). 196 
14.  I. Poser et al., BAC TransgeneOmics: a high-throughput method for exploration of 197 
protein function in mammals. Nat Methods. 5, 409–15 (2008). 198 
15.  N. Kayagaki et al., Non-canonical inflammasome activation targets caspase-11. Nature. 199 
479, 117–21 (2011). 200 
16.  S. Rühl, P. Broz, Caspase-11 activates a canonical NLRP3 inflammasome by promoting 201 
K(+) efflux. Eur. J. Immunol. 45, 2927–2936 (2015). 202 
17.  M. L. Skowyra, P. H. Schlesinger, T. V. Naismith, P. I. Hanson, Triggered recruitment of 203 
ESCRT machinery promotes endolysosomal repair. Science. 360 (2018), 204 
doi:10.1126/science.aar5078. 205 
18.  R. Heilig et al., The Gasdermin-D pore acts as a conduit for IL-1β secretion in mice. Eur. 206 
J. Immunol. 48, 584–592 (2018). 207 
 - 9 - 
19.  C. L. Evavold et al., The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 208 
Secretion from Living Macrophages. Immunity. 48, 35-44.e6 (2018). 209 
 210 
Author Contributions 211 
S.R. and P.B. designed the study. S.R., K.S., B.D., R.H., J.C.S. and P.B. performed 212 
experiments, analyzed data, and wrote the manuscript. 213 
 214 
Acknowledgments 215 
We thank Prof. A. Hyman (MPI-CBG, Dresden, Germany) for CHMP4-GFP HeLa cells, Prof. 216 
A. Oberst (University of Washington, Seattle, USA) for DmrB-caspase-1, J. Pieters 217 
(Biozentrum, Basel) for support and discussions and C. Ramon-Barros for technical assistance. 218 
Microscopy analysis was performed at the Biozentrum and UNIL Imaging Core Facilities. This 219 
work was supported by grants from the Swiss National Science Foundation (310030_175576) 220 
and the ERC (ERC-2017-CoG – 770988 – InflamCellDeath) to P.B. and a Werner Siemens 221 
Fellowship (Fellowships for Excellence, University of Basel) to S.R.. The authors declare no 222 
competing financial interests. All data are available in the article or in the supplementary 223 
materials. Cell lines and plasmids are shared upon request. The authors apologize to 224 
investigators whose contributions were not cited extensively because of space limitations. 225 
 226 
Supplementary Materials 227 
Material and Methods 228 
Fig. S1-S18 229 
Movies S1-S8 230 
 231 
 232 
Figure legends 233 
 - 10 - 
 234 
Figure 1. GSDMD-induced calcium flux negatively regulates pyroptosis 235 
A-B. Fluo-8 (Ca2+ indicator) and PI signals in unstimulated or LPS-transfected wildtype and 236 
Gsdmd−/− BMDMs. Graphs show average data from n=22, 22, 28, and 30 cells. C. Acquisition 237 
of PIlo signal in Ca2+ influx-negative wildtype, Casp11−/− and Gsdmd−/− BMDMs treated as in 238 
A. Graphs show average data from n=29, 29, and 26 cells. D. LDH release from BAPTA-AM-239 
treated BMDMs mock- or LPS-transfected for 2 hours. E. GSDMD processing in HA-240 
GSDMD-transgenic iBMDMs 2 hours post LPS transfection. F-G. LDH release and GSDMD 241 
processing in untreated or BAPTA-AM-treated HeLa cells infected with ∆sifA S. typhimurium 242 
for 5 hours. Graphs (C, E) show mean ± SD. **P <0.01; **** P<0.0001; ns, not significant; 243 
Student’s t-test. Results are representative of at least three independent experiments. 244 
 245 
Figure 2. The ESCRT machinery translocates to the plasma membrane during pyroptosis 246 
A. Fixed-cell microscopy images and CHMP4-GFP puncta quantification of CHMP4-247 
GFP/Dox-inducible GSDMDNT double-transgenic HeLa cells treated with 1 µg/ml of Dox for 248 
4.5 hours. B-C. Time-lapsed confocal images of either (B) CHMP4-mCherry-expressing or 249 
(C) CHMP4-GFP-expressing DmrB-Casp-1-transgenic HEK293T cells stained with Annexin-250 
V as membrane marker. Insets show CHMP4 localizing to plasma membrane or neck of 251 
budding vesicles. D. Close-up of Annexin-V+ vesicle released from CHMP4-mCherry- and 252 
GSDMD-GFPinternal-expressing DmrB-Casp-1-transgenic HEK293T cells after 1-hour 253 
homodimerizer treatment. Graphs show mean ± SD.*P <0.05; **P<0.01; Student’s t-test. 254 
Results are representative of at least three independent experiments. Arrowheads indicate 255 
CHMP4 puncta. Scale bars are 5 (A), 10 (B- C), and 1 µm (D).  256 
 257 
Figure 3 ESCRT inactivation enhances non-canonical inflammasome-induced pyroptosis 258 
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A-D. PI staining, LDH release, IL-1b release and caspase-1 processing from VPS4AWT- or 259 
VPS4AE228Q-transgenic iBMDMs 2 hours after LPS transfection. E-F. LDH release, IL-1b 260 
release, and GSDMD processing from VPS4AWT- or VPS4AE228Q-transgenic iBMDMs 2 hours 261 
post LPS transfection in the presence or absence of 2.5 µM MCC950. G. LDH and IL-1b 262 
release 4 hours post LPS transfection from Ripk3−/− iBMDMs treated with the respective 263 
siRNA. Graphs show mean ± SD. **P <0.01; ***P<0.001, ****P<0.0001; ns, not significant; 264 
Student’s t-test. Results are representative of at least three independent experiments. 265 
VPS4AWT/E228Q expression in A-F was induced with 0.5 µg/ml of Dox for 6 hours.  266 
 267 
Figure 4. ESCRT negatively regulates pyroptosis and cytokines release downstream of 268 
caspase-1 269 
A-B. LDH release, IL-1b release, processing of caspase-1 and GSDMD from VPS4AWT/E228Q-270 
transgenic iBMDMs infected with log-phase S. typhimurium for 1 hour. C. Time course of PI 271 
staining in DmrB-Casp1-transgenic HEK293T cells expressing FLAG-hGSDMD-V5 and 272 
Dox-inducible VPS4A or CHMP3 constructs. Cells were treated with 25 nM B/B 273 
homodimerizer (B/B HD) at t=0 and 50-fold excess washout compound at t=30 minutes. D. 274 
LDH release at t=120 minutes from DmrB-Casp1-transgenic HEK293T cells treated as in C, 275 
except for varying B/B HD concentrations. Immunoblots show equal expression levels of 276 
VPS4A proteins. E. GSDMD processing at t=60 minutes of DmrB-Casp1-transgenic 277 
HEK293T cells treated as in C, except for 50 nM B/B HD. F. LDH and IL-1b release at t=90 278 
minutes from DmrB-Casp1- and pro-IL-1b-double transgenic HEK293T expressing FLAG-279 
hGSDMD-V5 and Dox-inducible VPS4A constructs. Cells were treated with B/B HD at t=0 280 
and 50-fold excess washout compound at t=30 minutes. Graphs show mean ± SD. *P<0.05; 281 
**P <0.01; ***P<0.001, ****P<0.0001; Student’s t-test (A, D, F) or two-way ANOVA (C). 282 
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Results are representative of at least three independent experiments. Protein expression was 283 
induced for 6 hours (0.5 µg/ml of Dox, A-B) or 16 hours (1 µg/ml of Dox, C-F).  284 
 285 
 286 
 287 
 288 
 289 
 290 
 291 
 292 
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Materials and Methods 
Cell culture. BMDMs were differentiated in DMEM (Sigma-Aldrich) with 10% v/v FCS (Amimed), 10% MCSF 
(L929 cell supernatant), 10 mM HEPES (Amimed), and nonessential amino acids (NEAA, Amimed). For seeding, 
medium was aspirated and replaced with 5 ml ice cold PBS. Dishes were incubated at 4 °C for 15 minutes, cells were 
lifted using a cell scraper (Sarstedt) and collected. Cells were centrifuged (200 ´ g, 5 min, 4 °C), resuspended in the 
specified assay medium (see below) and counted. Immortalized BMDMs (iBMDMs) were described previously and 
maintained in DMEM supplemented with 10% FCS, 10% 3T3-MCSF-conditioned medium and 1 ´ PenStrep 
(Amimed). HeLa and HEK 293T cells were cultured in DMEM with 5% FCS and 1 ´ PenStrep (Amimed). For 
retrovirally transduced cell lines, cells were cultured in medium with respective antibiotics until the day prior to an 
experiment. 
Knock-down. Immortalized Ripk3–/– BMDMs were forward transfected with siRNA (30 pmol per 1 × 106 cells per 
well) in six-well plates using Lipofectamine RNAiMAX (Life technology) according to the manufacturer's 
instructions. Medium was replaced at 4 hours post-transfection for complete iBMDMs medium. After 48 hours, cells 
were reseeded into a 96-well plate (5 × 104 cells/well) for subsequent experiments and incubated for an additional 24 
hours. RNAi efficiency was assessed by immunoblotting at 72 hours post-transfection. SiRNAs (siGenome 
SMARTpool) were purchased from Dharmacon: Non-Targeting siRNA Pool #2 (D-001206-14-05), CHMP3 siRNA 
(M-062411-01-0005), VPS4A siRNA (M-046156-00-0005), VPS4B siRNA (M-044487-01-0005), ALIX siRNA (M-
062173-00-0005), ALG2 siRNA (M-062699-01-0005), Ptpn23 siRNA (M-062317-01-0005) and TSG101 siRNA (M-
049922-01-0005).  
LPS transfection. BMDMs or iBMDMs were seeded in assay medium (DMEM, 10% FCS, 10% 3T3-MCSF-
conditioned medium, 10 mM Hepes and 1 ´ NEAA) 1 day prior to stimulation at a density of 3 ´ 104 (BMDMs) or 5 
´ 104 (iBMDMs) cells per well in 96-well plates and grown overnight at 37 °C and 5% CO2. The next day, supernatant 
was removed and the cells were primed for 4 hours with 100 µl per well of 0.2 µg/ml Pam3CSK4 or 0.5 µg/ml LPS 
O55:B5 in complete medium. LPS/FuGeneHD complexes were prepared by mixing 100 µl Opti-MEM (Gibco) with 
ultrapure LPS O111:B4 (Invivogen) and 0.5 µl of FugeneHD (Promega) per 5 ´ 104 cells to be transfected. The 
transfection mixture was vortexed briefly, incubated for 5 minutes at room temperature and added dropwise to the 
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cells. Plates were centrifuged at for 5 minutes at 200 ´ g and 37 °C. Cells were incubated for indicated times at 37 °C 
and 5% CO2 and cell death and IL-1b levels were determined as described below.  
Stimulation of canonical inflammasomes. BMDMs and iBMDMs were seeded at a density of 5 ´ 104 cells per well 
of a 96-well plate and grown overnight in DMEM, 10 % FCS, 10 % 3T3-MCSF-conditioned medium, 10 mM Hepes, 
1 ´ NEAA (complete medium). Cells were primed in complete medium with 500 ng/ml LPS (O55:B5, Invivogen) for 
4 hours unless stated otherwise. Cells were washed once with PBS and 100 µl of Opti-MEM was added to each well. 
Stimuli were prepared in additional 100 µl of Opti-MEM to yield a final volume of 200 µl per well. Salmonella 
enterica serovar Typhimurium (referred to as S. typhimurium) SL1344 was grown to log phase (OD 1.4-1.8) in LB, 
diluted in Opti-MEM to the respective MOI and added to the cells. The plate was centrifuged for 5 minutes at 200 ´ 
g. Cells were incubated at 37 °C and 5% CO2 for 45 to 60 minutes and samples were processed as required. 
Poly(dA:dT) (Invivogen) was transfected using 0.5 µg linear PEI (Polysciences, 1 mg/ml stock) by preparing desired 
amounts of poly(dA:dT) in 50 µl Opti-MEM per well and 10 µg/µl PEI separately. Fifty microliters of PEI solution 
was added to poly(dA:dT) solution and mixture was incubated 10 minutes at room temperature. One hundred 
microliters were added to cells and stimulation was carried out 1-3 hours prior to sample collection.  
Inhibitor treatment. Cells were washed once with pre-warmed PBS and 100 µl of Opti-MEM supplemented with 2 
´ of the final inhibitor was added per well of a 96-well plate. Cells were pre-incubated at room temperature (BAPTA-
AM) or 37 °C (MCC950) for 30-45 minutes. Medium for HeLa cells or iBMDMs was supplemented with 1 mM 
Probenecid (Sigma) to inhibit efflux of BAPTA-AM. Cells were subsequently treated with respective stimulus (LPS 
transfection, poly(dA:dT) transfection, S. typhimurium) prepared in 100 µl medium without inhibitor and added to 
cells to yield a final concentration of 1 ´ of the respective inhibitor. Volumes were scaled up accordingly for 12-well 
plates to prepare samples for SDS-PAGE analysis.  
Cytokine and LDH release measurement. IL-1b was measured by ELISA (eBioscience). LDH was measured using 
LDH Cytotoxicity Detection Kit (Clontech). To normalize for spontaneous lysis, the percentage of LDH release was 
calculated as follows: (LDH treated - LDH untreated WT cells or medium control) / (LDH total lysis - LDH untreated 
WT cells or medium control) ´ 100. Plates were read using a Cytation 5 plate reader (BioTek).  
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Resazurin cell viability assay. Cells were washed once with pre-warmed PBS and incubated for 3 h with 100 µl 
iBMDMs medium supplemented with 16 µg/ml Resazurin (Sigma-Aldrich). Plates were read using a Cytation 5 plate 
reader (BioTek) according to the manufacturer’s instructions. To determine percentage of cell viability values were 
normalized to untransfected cells.  
ASC speck immunofluorescence. iBMDMs were plated at 2 ´ 105 cells per well in 24-well plates on sterile glass 
coverslips (13-mm diameter) in 1 ml of assay medium. Cells were allowed to attach overnight and cells were 
stimulated the next day as outlined above. After stimulation, coverslips were washed with PBS and fixed with 4% 
PFA at room temperature (RT) for 20 minutes. Following fixation, coverslips were washed with PBS and excess PFA 
was quenched using 100 mM glycine in PBS for 5 minutes. Coverslips were washed two times with PBS and 
permeabilized using 0.1% Triton (vol/vol) in PBS for 5 minutes. Coverslips were washed three times with PBS and 
coverslips were transferred to a humidity chamber and blocked with 200 µl of 5 % FCS in PBS for 1 h. Coverslips 
were stained with a monoclonal anti-ASC antibody (rat, 2 µg/ml, Genentech Inc.) in PBS containing 2% FCS for 1 
hour at RT. Following staining, coverslips were washed three times 2 minutes with PBS and stained with an Alexa-
568 conjugated anti-rat antibody (4 µg/ml, goat-anti-rat Alexa 568, life technologies, A11077) for 1 hour at RT in the 
dark. Coverslips were washed three times 5 minutes with PBS and mounted on glass slides using 2 µl Vectashield® 
mounting medium containing DAPI and sealed with nail polish. Slides were analyzed on a LSM700-Upright point 
scanning confocal microscope at 40 ´ magnification. Images were analyzed with Image-J, ASC specks and cells per 
field of view were counted manually. Four images (at least 100 cells per condition) from two coverslips were 
quantified per experiment.  
Infection of HeLa cells and bacterial invasion assays. HeLa cells stably transduced with HA-tagged Dox-inducible 
VPS4A or CHMP3 were seeded at density of 2.5 ´ 104 cells per well in 96-well plates and protein expression was 
induced using 1.0 µg/ml Dox for 12 hours. ∆sifA S. typhimurium SL1344 was grown overnight in low salt LB medium 
supplemented with 20 µg/ml kanamycin (Sigma), sub-cultured 1:50 in fresh LB with kanamycin and grown for 3 
hours until a late exponential phase (OD600 of 1.5). Bacteria were then added to the cells at the indicated MOIs and 
the plate was centrifuged for 5 minutes at 200 ´ g and 37 °C. Cells were incubated at 37°C for 30 minutes and 
gentamycin (Amimed) was added to a final concentration of 50 µg/ml to kill extracellular bacteria. After another 30 
minutes, cells were washed once with warm medium and then fresh medium supplemented with 10 µg/ml gentamycin 
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was added. Infection was allowed to proceed for the indicated time points before cells were processed for LDH, 
immunoblot analysis or for enumeration of intracellular bacteria. To count the number of intracellular bacteria, 
infected cells were gently washed with PBS, lysed with distilled water containing 0.2% Triton X-100, and bacteria 
were then serially diluted and plated onto LB agar plates.  
SCV rupture assays. HeLa cells stably transduced with HA-tagged Dox-inducible VPS4A or CHMP3 constructs 
were seeded one day before transfection with a plasmid encoding galectin3-eGFP, using the X-treameGENE 9 DNA 
Transfection Reagent (Roche) for 48 hours, according to the manufacturer’s instructions. Protein expression was induced 
using 1.0 µg/ml Dox for 12 hours and cells were infected with ∆sifA S. typhimurium SL1344-expressing mCherry 
grown until a late exponential phase. Here, bacteria were added to the cells at a MOI of 100 and incubated for 10 min 
at 37°C, so that a synchronized infection could be followed. Non-internalized bacteria were washed three times with 
warm medium and incubated up to 30 min at 37°C, before extracellular bacteria were killed by adding medium 
containing 50 µg/ml gentamicin. At 1 h post-invasion, cells were washed with PBS, fixed with 4% PFA at RT for 20 
minutes and imaged by confocal microscopy.  
Cell lysis and immunoblotting. For immunoblots cells were plated and stimulated in 12-well plates at 5 ´ 105 cells 
per well. After stimulation/infection in Opti-MEM plates were transferred on ice and the supernatants were collected 
in a new tube. Cells were washed once with ice-cold PBS and lysed in RIPA buffer (150 mM NaCl, 1% NP40, 0.5% 
sodium deoxycholate and 0.1% SDS, pH 7.4). Lysates were transferred to new tubes and incubated for 15 minutes on 
ice. Subsequently lysates were centrifuged (21,000 ´ g, 10 min, 4 °C) and cytosolic extracts were transferred to new 
tubes. The protein concentration was determined by the BCA method, adjusted to the lowest concentration with water 
and diluted 1:4 with 5 ´ Laemmli buffer. Lysates were boiled for 5 minutes at 95 °C and stored at -20 °C until further 
processing. TCA was added to supernatants a final concentration of 5% (vol/vol) to precipitate proteins and 
supernatants were kept on ice for 15 minutes. Supernatants were centrifuged (21,000 ´ g, 10 min, 4 °C), and pellets 
were washed with 1 ml of ice-cold acetone and centrifuged again as above. Acetone was discarded and pellets were 
air-dried and resuspended in 1 ´ Laemmli buffer supplemented with 100 mM Tris and boiled at 95 °C for 10 minutes. 
If combined lysates and supernatants were analyzed, the protein concentration was not adjusted but precipitated 
protein pellets were resuspended in equal volumes of the respective cell lysates. Samples were processed for SDS-
PAGE and immunoblotting.  
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Calcium and PI flux analysis. BMDMs were seeded in 8-well Ibidi treat® dishes (Ibidi) at 6 ´ 105 cells per well the 
day before the experiment. Cells were primed in complete medium with 0.2 µg/ml Pam3CSK4 for 4 hours. Cells were 
washed once with HBSS (Gibco) and incubated in the dark at room temperature for 45 minutes in HBSS supplemented 
with 4 µM Fluo-8 (Abcam, ab142773) in the presence of 2 mM Probenecid (Sigma). Cells were washed twice with 
HBSS and left either unstimulated or transfected with LPS as described above. HBSS was supplemented with 60 µM 
propidium iodide. After centrifugation, cells were transferred to “FEI More” wide field microscope (Field Electron 
and Ion Company), equipped with a heated stage, CO2 supply and a Hamamatsu ORCA flash 4.0 cooled sCMOS 
camera. Cells were imaged every 30 seconds at 40 ´ magnification. After acquisition, single cells were segmented 
manually and analyzed for Fluo-8 and PI fluorescence using Fiji (https://imagej.net).  
Live cell imaging. For live imaging experiments, DmrB-Caspase-1-transgenic HEK293T cells were seeded in 8-well 
tissue-culture treated slides (Ibidi) one day prior to transfection. Cells were transfected with 100 ng of plasmid DNA 
using JetPRIME transfection reagent (Polyplus transfection) accordingly to manufacturer’s recommendations. For 
expression of proteins by doxycycline induction, medium was exchanged 8 hours post transfection and cells were 
treated with 1 µg/ml doxycycline for 16 hours. Live imaging experiments were performed using Zeiss LSM800 point 
scanning confocal microscope equipped with 63x Plan-Apochromat NA 1.4 oil objective, Zeiss ESID detector module, 
LabTek heating/CO2 chamber and motorized scanning stage. Prior to imaging, transfection medium was exchanged 
for HBSS (Gibco) supplemented with 2 % FCS, 1 % HEPES, 0.1 % cell culture antioxidant supplement (Sigma) and 
70 ng/well Pacific Blue™ Annexin V (BioLegend). For the time-lapse experiments, each cell was imaged every 30 
seconds at 63x magnification for 20 min in total, after which 2 µM (final concentration) of B/B homodimerizer was 
added directly to the well, and the same cells were imaged for additional 20 to 40 min. For the imaging of late stage 
pyroptotic cells, z-stacks of single cells were acquired approximately 1 hour post B/B homodimerizer addition.  
Analysis of PI negative cells. Cells were segmented manually using Brightfield images and PI incorporation was 
quantified using Fiji. (Ft-F0)/F0 values of 15 unstimulated cells were calculated and an average of these values was 
calculated for each time point to correct for spontaneous flux of PI across the plasma membrane. (Ft-F0)/F0 of single, 
PI-negative cells from LPS-transfected conditions were calculated for each movie time point and the average PI value 
of the 15 unstimulated cells for the respective time point was subtracted to assess if enhanced PI incorporation caused 
by LPS transfection occurs. Curves were plotted for single cells as shown in the figures.  
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Lentiviral transduction. To produce lentiviral particles, 1 ´ 106 HEK 239T cells were transfected with 2 µg lentiviral 
plasmid, 2 µg psPax2, and 0.4 µg VSV-G for 6 hours. Medium was exchanged and lentiviral particles were collected 
24 hours later. Two hundred fifty thousand cells were spin-infected with these particles and transduced cells were 
selected with appropriate antibiotic for 7 days. Selected cells were used for experiments.  
HEK293T transfection and stimulation. Cells were seeded in polylysine-coated 96-well plates (40,000 cells per 
well) one day prior to transfection. Cells were subsequently transfected with 300 ng of plasmid DNA and 3 ´ (wt/vol) 
linear PEI. For expression of proteins by doxycycline treatment, the medium was exchanged 8 hours post-transfection 
and cells were treated with 1 µg/ml doxycycline for 16 hours. Twenty-four hours post-transfection, cells were 
stimulated as indicated in the respective figures.  
HeLa infection. HeLa cells were seeded at density of 2.5 ´ 105 cells per well in 96-well plate one day prior to 
transfection. Salmonella enterica serovar Typhimurium (referred to as S. typhimurium) SL1344 ∆sifA was grown to 
stationary phase in low salt LB supplemented with 20 µg/ml kanamycin (Sigma). The overnight culture was sub-
cultured 1:50 in fresh LB with kanamycin and grown for 3 hours until an OD600 of 1.5 was reached. HeLa cells were 
infected with the indicated MOIs and the plate was centrifuged for 5 minutes at 200 ´ g and 37 °C. After 30 minutes 
gentamycin (Amimed) was added to a final concentration of 50 µg/ml to kill the extracellular Salmonella. After 
another 30 minutes, cells were washed once with PBS and then fresh medium supplemented with 10 µg/ml gentamycin 
was added. Infection was allowed to proceed for another 4 hours before cells were processed for LDH or immunoblot 
analysis.  
Expression of ESCRT wildtype and dominant-negative proteins. Human CHMP3 and VPS4A were amplified 
from cDNA and cloned into pRetroX Tet-On 3G (Clontech). GP2 packaging cells (Clontech) were transfected with 
the respective plasmids and VSV-G at a ratio of 8:1 using three times (wt/vol) PEI. Retroviral particles were collected 
after 36 and 72 hours, combined and cells were transduced by spin-infection (1,900 ´ g, 90 minutes). After two days, 
transduced cells were selected by puromycin selection for 6 days. Experiments were conducted with pools.  
Antibodies. Primary antibodies used (Manufacturer, Catalogue N°): polyclonal rabbit anti-ASC at 1 µg/ml (Adipogen 
AG-25B-0006), monoclonal mouse anti-HA at 1:1000 dilution (Enzo Life Science, ENZ-ABS-118-0200), anti-FLAG 
at 2 µg/ml (Stratagene, 200472-21), anti-caspase-1 p20 at 1 µg/ml (Adipogen, AG20B-0042), anti-GAPDH at 1:10000 
(Thermo scientific, AM4300), anti-V5 at 1:5000 (Thermo Scientific, R960-25), anti-actin at 1:20000 (Merck, 
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MAB1501), rabbit anti-gasdermin-D, at 0.6 µg/ml (Abcam ab209845), anti-RIPK3 at 1 µg/ml (rabbit; no. IMG-5523-
2, Imgenex); anti-VPS4A at 1.3 µg/ml (mouse; no. ab213526, Abcam); anti-VPS4B at 5 µg/ml (rabbit; no. ab224736, 
Abcam); anti-CHMP3 at a 1000-fold dilution (rabbit; no. ab175930, Abcam); anti-ALG2 at 0.0108 µg/ml (rabbit; no. 
ab133326, Abcam); anti-ALIX at a 1000-fold dilution (rabbit; no. pab0204, Covalab); anti-Tubulin at 0.1 µg/ml 
(rabbit; no. ab4074, Abcam).  
Densitometric quantification of western blots. Equal ROIs were used to quantify the processed form of GSDMD 
or caspase-1 using Fiji. For all conditions loading controls (e.g. actin, tubulin or gapdh) were quantified using Fiji. 
For not stimulated conditions unprocessed forms of proteins were normalized to loading controls (Ratio A), for 
stimulated conditions the processed form was normalized to loading controls (Ratio B). Subsequently the Ratio B of 
each stimulated condition was normalized to the respective Ratio A. In a second step, the ratio of medium-treated 
samples or ESCRT-WT proteins compared to BAPTA-AM-treated or ESCRT-DN samples were determined for each 
condition in order to compare different experimental repeats.  
Statistical analysis. Statistical tests were performed as described in the figure legends using GraphPad Prism 7 
(GraphPad Software, Inc., La Jolla, CA, USA). 
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Fig. S1. Ca2+ and PI influx measurements after non-canonical inflammasome activation. 
A. Percentage of PIhigh wildtype mouse BMDMs 2 hours after transfection with increasing amounts of LPS (0, 4.15, 
8.3 or 16.6 µg / 1 × 106 cells) in absence or presence of 3.3 µM BAPTA-AM. Cells were primed with LPS for 4 hours 
before transfection. Three fields of view were analyzed and PIhi cells enumerated manually. B. Time lapsed 
microscopy images of Ca2+ influx (Fluo-8) and membrane permeabilization (PI) in LPS-primed wildtype BMDMs 
after transfection of LPS (3.5 µg / 1 × 106 cells). Scale bars correspond to 5 µm. C-D. Single-cell analysis of Ca2+ 
(Fluo-8) and PI influx in LPS-primed wildtype, Casp11–/– and Gsdmd–/– BMDMs either unstimulated or transfected 
with LPS (3.5 µg / 1 × 106 cells). Graphs show three representative cells out of 25-30 analyzed per condition. See 
Material and Methods section for a detailed description of the calculation of Fluo-8 and PI intensity. Graphs show 
mean ± SD. ***P<0.001; Two-way ANOVA. Results are representative of at least three independent experiments. 
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Fig. S2. Ca2+ chelation enhances cell death after non-canonical inflammasome activation and permits cell 
survival at sub-lethal levels of LPS transfection. 
A. LDH release from LPS-primed wildtype mouse BMDMs after transfection with the indicated amounts of LPS in 
the presence or absence of 3.3 µM BAPTA-AM. BAPTA-AM control is only shown in first panel. B. LDH release 
from LPS-primed wildtype mouse BMDMs after transfection with 16.6 µg LPS per 1 × 106 cells for 2.5 hours in 
medium or in medium supplemented with the indicated amounts of Ca2+ chelators. Graphs show mean ± SD. *P<0.05; 
****P<0.0001; ns, not significant; student’s t-test. Results are representative of at least three independent experiments. 
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Fig. S3. Quantitative analysis of immunoblots from Figure 1E and 1G. 
Densitometric quantification (as described in Material and Methods) of the processed GSDMDNT band in untreated or 
BAPTA-AM-treated HA-GSDMD-transgenic immortalized wildtype BMDMs 2 hours post LPS transfection (A) or 
untreated or BAPTA-AM-treated HeLa cells infected with ∆sifA S. typhimurium at the indicated MOIs for 5 hours 
(B). Results show combined data of n=3 repeats. Results are expressed as intensity relative to untreated control. 
*P<0.05; ns, not significant; student’s t-test.  
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Fig. S4. CHMP4-GFP localizes to the plasma membrane upon pyroptosis induction. 
A. Fixed cell microscopy images of CHMP4-GFP-transgenic HeLa cells left untreated, treated with perforin (control) 
(200 µg/ml, 45 minutes), infected with ∆sifA S. typhimurium (MOI 100, 5 hours) or expressing GSDMDNT from Dox-
inducible promoter (1 µg/ml Dox, 4 hours). B. Fixed-cell microscopy images and quantification of CHMP4-GFP 
puncta from CHMP4-GFP/Dox-inducible GSDMDNT double-transgenic HeLa cells either left untreated or treated 
with Dox (1 µg/ml) for 4.5 hours. Membranes were stained with FM4-64FX. Scale bars correspond to 5 µm. Graphs 
show mean ± SD. **P<0.01; student’s t-test Results are representative of at least three independent experiments.  
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Fig. S5. Localization of CHMP4 in HEK293T cells after activation of DmrB-Casp-1 
A. Time-lapsed confocal images of high-level CHMP4-mCherry-expressing DmrB-Casp-1-transgenic HEK293T cells 
stained with Annexin-V as membrane marker. B-C. Time-lapsed confocal images of low level (B) and high level (C) 
CHMP4-GFP-expressing DmrB-Casp-1-transgenic HEK293T cells stained with Annexin-V as membrane marker. D-
E. Confocal images of CHMP4-mCherry- or CHMP4-GFP-expressing DmrB-Casp-1-transgenic HEK293T cells 
stained with Annexin-V as membrane marker after 1 hour B/B homodimerizer treatment (2 µM) (late stage 
pyroptosis). Insets show Annexin-V-positive budding vesicles. Arrows show CHMP4 puncta. Scale bars are 5 (A) and 
10 (B-D)  µm.  
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Fig. S6. Localization of CHMP4 in HEK293T cells after activation of DmrB-Casp-11. 
A. Time-lapsed confocal images of CHMP4-GFP-expressing DmrB-Casp-11-transgenic HEK293T cells stained with 
Annexin-V as membrane marker. B. Confocal images of CHMP4-GFP-expressing DmrB-Casp-11-transgenic 
HEK293T cells stained with Annexin-V as membrane marker after 1 hour B/B homodimerizer treatment (2 µM) (late 
stage pyroptosis). Insets show Annexin-V-positive budding vesicles. Arrows show CHMP4 puncta. Scale bars are 10 
µm.  
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Fig. S7. Localization of GSDMD during pyroptosis. 
A. Schematic outline of the expression construct for mouse GSDMD with internal GFP-tag (referred to as GSDMD-
GFPinternal). GFP tag was inserted between GSDMDNT and the linker region so that a GFP-tagged GSDMDNT is 
generated after cleavage. Of note, mouse GSDMD cannot be tagged N-terminal without loss of its pore-forming 
ability, since N-terminal residues are critical for membrane insertion and pore formation. B. Time-lapsed confocal 
images of CHMP4-mCherry- and GSDMD-GFPinternal-expressing DmrB-Casp-1-transgenic HEK293T cells stained 
with Annexin-V as membrane marker. B/B homodimerizer was added at 2 µM final concentration at t=0. Insets show 
close proximity of GSDMD and CHMP4 at peripheral regions. C. Examples of CHMP4-mCherry and GSDMD-
positive vesicles shed from CHMP4-mCherry- and GSDMD-GFPinternal-expressing DmrB-Casp-1-transgenic 
HEK293T after B/B homodimerizer treatment. Scale bars are 10 (B) and and 1 (C) µm.  
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Fig. S8. Generation and characterization of VPS4A-transgenic iBMDMs and VPS4A-/CHMP3-transgenic 
HeLa cells 
A. Schematic outline of pRetroX-Tet-On 3G plasmids used for the generation of cell lines with doxycycline (Dox)-
inducible expression of HA-tagged wild-type and dominant negative human CHMP3 and VPS4A. B. Expression of 
VPS4AWT or VPS4AE228Q in lysates of VPS4A-transgenic iBMDMs wildtype, Casp11–/– or Gsdmd–/– BMDMs from 
Fig. 3C and 3E after induction for 6 hours with 0.5 µg/ml Dox. Immunoblots show anti-HA and anti-actin (loading 
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control). C. Time course of protein expression of HA-tagged CHMP3WT, CHMP31-179, VPS4AWT or VPS4AE228Q in 
HeLa cells transgenic for Dox-inducible VPS4A or CHMP3 constructs after Dox treatment (1.0 µg/ml). Immunoblots 
show anti-HA and anti-actin (loading control). D. Subcellular distribution of wild-type and dominant-negative VPS4A 
or CHMP3 proteins in iBMDMs or HeLa cells from Fig. S7B-C. Cell lines were treated with 1 µg/ml Dox for 6 hours, 
fixed and stained for the HA-tag. Scale bars correspond to 5 µm. E. Cell viability measurement of HeLa stably 
transduced with Dox-inducible constructs for CHMP3WT, CHMP31-179, VPS4AWT or VPS4AE228Q after Dox treatment 
for up to 25 hours. Cells were stained with a live/dead marker and cell death was quantified by flow cytometry analysis. 
Graphs (E) show mean ± SD. ***P<0.001; ****P<0.0001; ns, not significant; student’s t-test. Results are 
representative of at least two independent experiments. 
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Fig. S9. Single-cell-based analysis of cell death in ESCRT-proficient and -deficient cells. 
A. Schematic outline of the experimental setup: VPS4AWT and VPS4AE228Q-transgenic immortalized WT 
macrophages are seeded to equal ratio into iBidi chamber wells. In experimental setup 1, VPS4AE228Q-transgenic 
immortalized WT macrophages express GFP to distinguish them from VPS4AWT-expressing cells. In experimental 
setup 2, the VPS4AWT-expressing cells express GFP and VPS4AE228Q- expressing cells are unlabeled. Cells are 
transfected with LPS (5 µg/ml) for 1 hour, before changing to imaging medium (HBSS) and imaging for up to 4 hours. 
B. Percentage of PIhi VPS4AWT and VPS4AE228Q-transgenic immortalized WT macrophages in experimental setup 1 
or 2 over time. Representatives movies: Movie file 7 and 8. ****P<0.0001; two-way ANOVA. Results are 
representative of at least two independent experiments. 
  
100 140 180 220 260 300 340
0
10
20
30
40
VPS4AWT
VPS4AE228Q
****
VPS4AWT VPS4AE228Q
LPS 
transfection
VPS4Atg immortalized WT BMDMs
t0
t4h
VPS4AE228QVPS4AWT
Quantification 
of PIhi cells
A B
Experimental setup 1 Experimental setup 2
%
 o
f P
Ihi  
ce
lls
Experimental setup 2
100 140 180 220 260 300 340
0
10
20
30
40
50
VPS4AE228Q
VPS4AWT
****
%
 o
f P
Ihi  
ce
lls
Experimental setup 1
Time (minutes)
  22 
 
Fig. S10. ESCRT inhibition reduces long-term viability after LPS transfection. 
A. Schematic outline of the long-term viability assay: VPS4AWT- or VPS4AE228Q-transgenic WT iBMDMs were 
primed with LPS (500 ng/ml) 2 hours after VPS4AWT- or VPS4AE228Q expression was induced by addition of 0.5 
µg/ml doxycycline. Four hours later, cells were left untransfected or transfected with 2.5-10 µg LPS per 1 × 106 cells. 
B. Supernatant were removed and processed for LDH analysis at 4 hours post transfection. C-D. Cells were thereafter 
washed with PBS to remove LPS, doxycycline and transfection reagent and fresh medium was added. Twenty-four 
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hours later, cell viability was assessed using resazurin (C) and representative images were acquired (D). Graphs show 
mean ± SD. **P <0.01; ***P<0.001; ns, not significant; student’s t-test. Results are representative of at least two 
independent experiments. 
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Fig. S11. Enhanced LPS-induced cell death after ESCRT inactivation requires Caspase-11 and GSDMD. 
A-B. LDH and IL-1b release from VPS4AWT- or VPS4AE228Q-transgenic iBMDMs 2 hours after LPS transfection. 
Graphs show mean ± SD. ****P<0.0001; Student’s t-test. Results are representative of at least three independent 
experiments. VPS4AWT/E228Q expression was induced with 0.5 µg/ml of Dox for 6 hours. 
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Fig. S12. Potassium efflux controls IL-1b release after LPS transfection in LPS-primed iBMDMs expressing 
VPS4AWT or VPS4AE228Q.  
A. LDH and IL-1b release from VPS4AWT- or VPS4AE228Q-transgenic iBMDMs after LPS transfection for 2 hours in 
the presence or absence of 55 mM extracellular KCl. B. Densitometric quantification (as described in Material and 
Methods) of the processed GSDMDNT band in VPS4AWT or VPS4AE228Q-expressing immortalized WT BMDMs 2 
hours post LPS transfection in presence of MCC950. Results show combined data of n=3 repeats. Results are 
expressed as intensity relative to the GSDMDNT in VPS4AWT-expressing immortalized WT BMDMs. The 
representative immunoblot is shown in Figure 3F. Graphs show mean ± SD. **P <0.01; ***P<0.001; ****P<0.0001; 
ns, not significant; student’s t-test. Results are representative of at least three independent experiments. 
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Fig. S13. Knock-down of ESCRT and ESCRT-associated proteins in Ripk3–/– iBMDMs. 
A-C. Characterization of immortalized Ripk3–/– BMDMs showing (A) immunoblots for RIPK3 and actin (control) in 
WT and Ripk3–/– iBMDMs, and (B-C) LDH and IL-1b release from WT or Ripk3–/– iBMDMs primed with LPS (500 
ng/ml) and treated with a combination of the pan-caspase inhibitor QVD (10 µM) and the SMAC mimetic LCL161 
(4 µM) to induce necroptosis. Rip3 inhibitor GSK’872 was used at 1 µM to block necroptosis induction. D. 
Immunoblots for ALIX, ALG2, CHMP3, VPS4A, VPS4B and actin (control) in Ripk3–/– iBMDMs transfected with 
non-targeting (NT) siRNA or siRNA for ALIX, ALG-2, CHMP3, VPS4A or VPS4B. Immunoblots were done at 72 
hours post-transfection. E. Images showing Ripk3–/– iBMDMs from A. F. Images and resazurin-based cell viability 
assay of Ripk3–/– iBMDMs transfected with non-targeting (NT) siRNA or siRNA for TSG101 or Ptpn23 for 72 hours. 
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Graphs show mean ± SD. **P<0.01, ****P<0.0001; student’s t-test. Results are representative of at least two 
independent experiments.  
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Fig. S14. ESCRT negatively regulates GSDMD-induced pyroptosis upon S. typhimurium infection of human 
epithelial cells.  
A-D. LDH release in VPS4AWT/E228Q or CHMP3WT/1-179 HeLa cells stably transduced with HA-tagged Dox-inducible 
VPS4A or CHMP3 constructs (CHMP3WT, CHMP31-179, VPS4aWT or VPS4aE228Q) after infection with different MOIs 
of DsifA S. typhimurium. Protein expression was induced using 1.0 µg/ml Dox for 12 hours and then cells were infected 
for 5 hours (A-B) or for the indicated time-points (C-D). E-F. HeLa cells stably transduced with HA-tagged Dox-
inducible VPS4A or CHMP3 constructs were seeded onto 96-well plates and infected with DsifA S. typhimurium for 
2 hours, in order to determine bacterial invasion. The levels of intracellular bacteria were assessed by gentamicin 
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protection assay and CFU counting after plating onto LB agar plates. In C-D, the MOI was lowered in order to have 
no pyroptotic cell death at early time-points upon bacterial invasion, which would negatively impair intracellular 
bacterial survival, as observed with MOIs > 50 (data not shown). Graphs shown in C-F correspond to the same 
experiment. Graphs show mean ± SD. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; ns, not significant; student’s 
t-test. Results are representative of at least three independent experiments performed in triplicate. 
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Fig. S15. ESCRTs regulate membrane integrity of the Salmonella-containing vacuole (SCV).  
A-C. HeLa cells stably transduced with HA-tagged Dox-inducible VPS4A or CHMP3 constructs (CHMP3WT, 
CHMP31-179, VPS4aWT or VPS4aE228Q) were transfected with a plasmid encoding galectin3-eGFP. Cells were then 
infected with DsifA S. typhimurium-expressing mCherry for 1 hour, fixed and imaged by confocal microscopy. 
Galectin3 accumulation can be used as a marker of lysed vacuoles, thus SCV rupture was quantified by assessing the 
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presence of intracellular bacteria positive for galectin3-eGFP. The percentage of infected cells containing galectin3-
positive S. typhimurium (A) or the percentage of intracellular bacteria positive for galectin3 (B) was quantified by 
counting at least 50 infected cells or 200 bacteria per coverslip, respectively. Representative fluorescence confocal 
microscopy images (C) show the accumulation of galectin3-eGFP (green) around intracellular bacteria (magenta). 
Images were acquired using a 63x/1.40-NA oil objective and data were analyzed using FiJi software. All derived 
images shown correspond to 3D maximum projections and scale bars correspond to 5 µm. D-E. GSDMD processing 
5 hours after infection with different MOIs of DsifA S. typhimurium in HeLa cells stably transduced with FLAG-
GSDMD-V5 and HA-tagged Dox-inducible VPS4A or CHMP3 constructs. GSDMD processing was analyzed in 
combined lysate and supernatants by immunoblotting. F. Densitometric quantification (as described in Material and 
Methods) of GSDMD processing from HeLa cells stably transduced with HA-tagged Dox-inducible VPS4A or 
CHMP3 constructs 5 hours after infection with different MOIs of DsifA S. typhimurium. In all experiments protein 
expression was induced using 1.0 µg/ml Dox for 12 hours. Graphs show mean ± SD. ***P<0.001; ****P<0.0001; ns, 
not significant; student’s t-test. Results are either pooled from two independent experiments performed in triplicate 
(A-B) or representative from two (C) or three (D-F) independent experiments. 
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Fig. S16. Calcium chelation enhances cell death but not caspase-1 processing after AIM2 activation.  
A-C. LDH release and caspase-1 processing in untreated or BAPTA-AM-treated Nlrp3–/– BMDMs transfected with 
poly(dA:dT) for 2 hours. D. Densitometric quantification (as described in Material and Methods) of the processed 
caspase-1 p20 band in untreated or BAPTA-AM-treated Nlrp3–/– BMDMs 2 hours post poly(dA:dT) transfection. 
Results show combined data of n=3 repeats. Results are expressed as intensity relative to the caspase-1 p20 in untreated 
controls. A representative immunoblot is shown in Figure S16C. Graphs show mean ± SD. *P<0.05; **P <0.01; 
***P<0.001; ns, not significant; student’s t-test. Results are representative of at least three independent experiments. 
Nlrp3–/– BMDMs are used to avoid GSDMD-dependent activation of NLRP3 and subsequently enhanced caspase-1 
processing. 
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Fig. S17. ESCRT inhibition enhances pyroptosis after canonical inflammasome activation. 
A. Percentage of cells with ASC specks in VPS4AWT- or VPS4AE228Q-transgenic wildtype iBMDMs after infection 
with log-phase S. typhimurium (MOI 10) for 1 hour. ASC specks were visualized by immunofluorescence and counted 
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as described in Material and Methods. B. LDH release from immortalized wild-type or Gsdmd-/- BMDMs stably 
transduced with indicated Dox-inducible VPS4A constructs after infection with S. typhimurium (MOI 5) for 1 hour. 
C. Immunoblot for caspase-1 processing in Gsdmd-/- iBMDMs stably transduced with indicated Dox-inducible 
VPS4A constructs after infection with log-phase S. typhimurium (MOI as indicated) for 1 hour. D. Densitometric 
quantification (as described in Material and Methods) of the processed caspase-1 p20 in VPS4AWT- or VPS4AE228Q-
transgenic Gsdmd-/- iBMDMs infected with log-phase S. typhimurium for 1 hour. Results show combined data of n=3 
repeats. Results are expressed as intensity relative to the processed protein in VPS4AWT-expressing cells. A 
representative immunoblot is shown in Figure S18C. E. Densitometric quantification (as described in Material and 
Methods) of the processed caspase-1 p20 and GSDMDNT bands in VPS4AWT- or VPS4AE228Q-transgenic wildtype 
iBMDMs infected with log-phase S. typhimurium for 1 hour. Results show combined data of n=3 repeats. Results are 
expressed as intensity relative to the processed protein in VPS4AWT-expressing cells. A representative immunoblot is 
shown in Figure 4B. Graphs show mean ± SD. ** P <0.01; ns, not significant; student’s t-test. Results are 
representative of at least three independent experiments. Protein expression in A-C was induced with 0.5 µg/ml Dox 
for 12 hours.  
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Fig. S18. ESCRT inhibition enhances cell death upon B/B homodimerizer-induced activation of DmrB-Casp-1. 
A. Time course of PI staining in DmrB-Casp1-transgenic HEK293T cells expressing FLAG-hGSDMD-V5 and Dox-
inducible VPS4A constructs. Cells were treated with 25 nM B/B homodimerizer at t=0 and (optionally) 50-fold excess 
washout compound at t=30 minutes. B. LDH release at 120 minutes post treatment from DmrB-Casp1-transgenic 
HEK293T cells expressing Dox-inducible CHMP3 constructs treated as in A, except for varying B/B homodimerizer 
concentrations. Immunoblots show equal expression levels of CHMP3 proteins. C. Densitometric quantification (as 
described in Material and Methods) of the processed GSDMDCT band at 1 hour post treatment in DmrB-Casp1-
transgenic HEK293T cells expressing FLAG-hGSDMD-V5 and Dox-inducible CHMP3 constructs. Cells were treated 
with 25 nM B/B homodimerizer at t=0 and 50-fold excess washout compound at t=30 minutes. Results show combined 
data of n=3 repeats. Results are expressed as intensity relative to the processed protein in CHMP3WT-expressing cells. 
A representative immunoblot is shown in Figure 4E. D-E. LDH release from DmrB-Casp1-transgenic HEK293T cells 
expressing FLAG-hGSDMD-V5 or Luciferase, and Dox-inducible VPS4A/CHMP3 constructs. Cells were treated 
with 25 nM B/B homodimerizer at t=0 and 50-fold excess washout compound at t=30 minutes. F. LDH and IL-1b 
release at t=90 minutes from DmrB-Casp1- and pro-IL-1b-double transgenic HEK293T expressing FLAG-hGSDMD-
V5 and Dox-inducible VPS4A constructs. Cells were treated with B/B HD at t=0 and 50-fold excess washout 
compound at t=30 minutes. Graphs show mean ± SD. *P<0.05; **P<0.01; ***P<0.001; ****P<0.0001; ns, not 
significant; student’s t-test. Results are representative of at least three independent experiments. Expression of WT or 
dominant-negative ESCRT proteins was induced for 16 hours (1 µg/ml doxycycline).  
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Movie Captions 
 
Movie 1. Pam3CSK4-primed wildtype (left) and Casp11-deficient (right) BMDMs were loaded with 4 µM Fluo-8 
(green) and subsequently transfected with LPS. Images were acquired in the presence of PI (red) every 30 seconds. 
Time is shown in minutes:seconds. 
 
Movie 2. Pam3CSK4-primed wildtype (left) and Gsdmd-deficient (right) BMDMs were loaded with 4 µM Fluo-8 
(green) and subsequently transfected with LPS. Images were acquired in the presence of PI (red) every 30 seconds. 
Time is shown in min:seconds 
 
Movie 3. CHMP4-GFP HeLa cells stably transduced with Dox-inducible GSDMDNT were treated with doxycycline 
for 3 hours and subsequently imaged. Images were acquired every 10 seconds in the presence of PI (red). Time is 
shown in minutes:seconds. 
 
Movie 4. Related to Figure 2B. Time-lapsed confocal images of either CHMP4-mCherry-expressing DmrB-Casp-1-
transgenic HEK293T cells stained with Annexin-V as membrane marker. A cell expressing high level CHMP4 was 
chosen for imaging. B/B homodimerizer was added at t=0.  
 
Movie 5. Related to Figure 2C. Time-lapsed confocal images of either CHMP4-GFP (in red)-expressing DmrB-Casp-
1-transgenic HEK293T cells stained with Annexin-V as membrane marker. A cell expressing high level CHMP4 was 
chosen for imaging. B/B homodimerizer was added at t=0. 
 
Movie 6. Related to Figure S5A. Time-lapsed confocal images of either CHMP4-mCherry-expressing DmrB-Casp-
1-transgenic HEK293T cells stained with Annexin-V as membrane marker. A cell expressing high level CHMP4 was 
chosen for imaging. B/B homodimerizer was added at t=0. 
 
Movie 7. Related to Figure S9. VPS4AWT (GFP-labeled)- and VPS4AE228Q (unlabeled) expressing immortalized WT 
macrophages were transfected with LPS and imaged in the presence of PI (red) every 5 minutes. 
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Movie 8. Related to Figure S9. VPS4AWT (unlabeled)- and VPS4AE228Q (GFP-labeled) expressing immortalized WT 
macrophages were transfected with LPS and imaged in the presence of PI (red) every 5 minutes. 
 
